Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | Cancer Cell International

Fig. 2

From: Imiquimod inhibits growth and induces differentiation of myeloid leukemia cell lines

Fig. 2

Imiquimod and R848 induce growth inhibition in various types of leukemic cell lines. The indicated leukemic cell lines were treated with Imiquimod at 10 µg/ml (a) or R848 at 25 µg/ml (b) for 72 h. Control cultures for each cell line were performed in the absence of TLR ligands. Cell growth, expressed as the percentage of cell viability relative to the control cultures (100%) for each cell line, was assessed in duplicate samples. Results are expressed as mean ± SD of pooled data from two experiments. *P < 0.05, and **P < 0.01 with respect to control untreated cells

Back to article page